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A Derivation of the test statistic
Here we derive the proposed test statistic. Note that a more intuitive explanation of the setting is given in the paper.
Setting
The setting is similar to Goeman et al. (2004) . Denote the response across all samples by y = (y 1 , . . . , y n )
T , and the library sizes by m = (m 1 , . . . , m n ) T . Each y i is modelled by E[y i |r i ] = γ i exp(α + r i ), where α is the intercept, log(γ i ) an offset, and r i a realisation of the random effect. We use γ i = m i /m, where m = ( n i=1 m i )
(1/n) . For the random vector r = (r 1 , . . . , r n ) T we assume E[r] = 0 and Var[r] = τ 2 XX T , where X is the n × p covariate matrix. The aim is to test H 0 : τ 2 = 0 against H 1 : τ 2 > 0. For simplicity we define R = (1/p)XX T and let R ij denote the element in the i th row and j th column of R.
Distribution
We assume y i |r i ∼ NB(µ i , φ), where µ i > 0 and φ > 0 for all i = 1, . . . , n. 
Score
Le Cessie and van Houwelingen (1995) show how to obtain the score for testing H 0 : τ 2 = 0 against H 1 : τ 2 > 0. The calculations from le Cessie and van Houwelingen (1995) start with the marginal likelihood function:
The crucial step of le Cessie and van Houwelingen (1995) is to take the Taylor expansion with respect to the random effect before taking the expectation. Differentiating this approximation of L(α, τ
2 ) with respect to τ 2 , and evaluating the result at τ 2 = 0 gives the score. Under the null hypothesis only some terms of the score can be different from zero:
Plugging the expressions for l
(1)
Parameter estimation
Under the null hypothesis we have y i ∼ N B(µ i , φ) where µ i = γ i exp(α). Maximum likelihood estimation leads toα = log(ȳ) − log(γ). The maximum likelihood estimate for the dispersion parameter φ can be obtained by numeric maximisation.
Test statistic
In matrix notation the test statistic is 
B Cancer dataset Variables
The prostate cancer dataset from TCGA et al. (2013) includes data of various types and on three different levels. We used preprocessed forms of the RNA-Seq data (gene, level 3), of the DNA methylation data (human methylation 450 array, level 3), and of the DNA copy number data (CNV data extracted from SNP array, level 3). The last-mentioned data involves copy numbers measured at equally spaced loci on the genome, obtained from the segmented copy number profiles.
Samples
Our criterion for sample selection was the availability of gene expression, methylation, copy number and single nucleotide polymorphism data. This lead to a sample size of 162 individuals.
Normalisation TCGA et al. (2013) use MapSplice (Wang et al., 2010) and RSEM (Li & Dewey, 2011) for calculating RNA-Seq gene expression data. The methylation data from TCGA et al. (2013) consists of the calculated beta values, i.e. the ratios between the methylated and the total probe intensities, mapped to the genome. We use the logit transformation to obtain values on the real line. In contrast, we do not modify the normalised copy number data from TCGA et al. (2013) .
Batch effects
According to the TCGA batch effects tool (MD Anderson Cancer Center, 2016) , the between batch dispersion (DB) is much smaller than the within batch dispersion (DW) in the RNA-Seq gene expression data, the copy number data, and the methylation data. Due to the small dispersion separability criteria (DSC = DB/DW) we do not correct the data for batch effects. Figure A: ROC curves from the simulation study. Given an 128 × 1 000 covariate matrix and a coefficient vector of length 1 000, we show how the area under the curve depends on the dispersion parameter (default φ = 0.01), the sample size (default n = 128), the effect size (default s = 1), and the number of non-zero coefficients (default r = 20). At all times only one of the parameters differs from its default value. For each line we simulate 10 000 expression vectors, and each expression vector is simulated under the alternative hypothesis with a probability of 50%. Table A : Type I error rates in the simulation study. Under each simulation setup from Figure A we calculate the type I error rates at the 5% (top) and 1% (bottom) significance levels. The row and column names match the entries with the lines in Figure A . As the average rates are 5.1% and 1.0% respectively, there is little concern about rejecting more true null hypotheses than expected. Additional Note: In order to verify that the type I error rate is not only maintained across genes, but also for individual genes, we simulate 5000 expression vectors y = (y 1 , . . . , y 128 ) T from the negative binomial distribution with µ = 7 and φ = 0.1. Testing for associations with the given covariate matrix X leads to the type I error rates 4.4% and 0.7% at the 5% and 1% significance levels, respectively. Table B : Statistical power of joint and individual testing at various significance levels α. We simulate 1 000 response vectors under the alternative hypothesis (n = 128, p = r = 50, s = 1, φ = 0.01). After testing the covariates jointly as well as individually, we compare the joint p-value with the minimum of the FDR-corrected individual p-values. Joint testing rejects a higher percentage of false null hypotheses than individual testing. LDHC  CLEC4E  ZNF774  RNF125  BMP8A  HLA-DRB1 APIP  ST8SIA1  RPS2  CLIP3  KTI12  HLA-DQA2 SLC35C1 MTERF2  CDIP1  SPINT4  ID2  HLA-DQB2 ACP2  RAB35  TEKT5  KRTAP8-1  POMC  B4GALT1  PTPMT1 MPHOSPH9 LCAT  SHISA8  KCNK3  NUDT2  YPEL4  GOLGA5  ZSWIM7  CCR4 FAM24A LTBR EMC7 NUFIP2 At any reasonable significance level, the non-stratified permutation test (grey) rejects more null hypotheses than the stratified permutation test (black). Naturally, genetic variation is high between and low within populations. Ignoring population structure increases genetic variation and thereby statistical power, whereas accounting for population structure decreases bias. 
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Figure C: Comparison with known associations. In the application HapMap only these 10 genes have a covariate group that is declared jointly significant by the proposed test 1 and that includes at least one individually significant SNP as found by Lappalainen et al. (2013) 2 . We decompose the corresponding proposed test statistics to obtain the contributions (y-axes) of the individual SNPs (indices on x-axes). Whereas 79% of the individually significant SNPs (black) from Lappalainen et al. (2013) have a positive contribution to the proposed test statistics, this is only true for 45% of the other SNPs (grey).
1 We obtain a p-value equal to the reciprocal of the number of permutations in the application HapMap. Figure E: Cumulative distribution functions of RNA-Seq from the application TCGA for randomly selected genes. Each row represents one gene, and each column represents one model. It is of interest how close the fitted distributions (red) come to the empirical distributions (black). Whether library sizes are ignored (columns 1 and 2) or an offset is included (columns 3 and 4), the negative binomial distribution with a free dispersion parameter has a much better fit than the Poisson distribution. VPS13D  KPNA6  TACSTD2 PRKAB2  NUCKS1  RER1  CTRC  ZBTB8A  ROR1  HIST2H2AB FAM72A  NPHP4  FBXO42  TEKT2  SYDE2  PSMD4  RASSF5  ACOT7  SZRD1  THRAP3  EPHX4  BGLAP  HLX  TAS1R1  CNR2  ZMPSTE24 CCDC18  NUF2  MRPL55  ZBTB48  SRSF10  PPCS  GPR88  ADCY10  EXOC8  CAMTA1  TMEM50A ERMAP  PSRC1  TNFSF4  OR2L13  PARK7  SEPN1  CFAP57  FAM19A3 RC3H1  TARDBP  PIGV  TMEM125  TRIM33  ASTN1  CLCN6  GPN2  SZT2  NRAS  DHX9  KIAA2013 PPP1R8  KLF17  ATP1A1  PRG4   Table E : List of gene symbols. In the application TCGA these genes are insignificant in both individual tests but significant in the joint test at a false discovery rate of 5%. Their expression is associated with methylations and copy numbers jointly, but with neither of them individually.
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